In the control group, the robust adaptive response, which controlled the infection, was associated with levels of circulating IFN-γ+ T cells that were significantly higher than in any of the benznidazole-cured mice by 40 days post-challenge (Fig 5B). This evidence concerns the gene IFNG and infection.